Clinical trials
Phase 2 Hyperlipoproteinemia Type II trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kastle Therapeutics, LLC | 2 |
| Medical Research Laboratories International | 2 |
| Akros Pharma Inc. | 1 |
| Cerenis Therapeutics, SA | 1 |
| Japan Tobacco Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| The Medicines Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 9 |
| Homozygous Familial Hypercholesterolemia | 3 |
| Atherosclerosis | 2 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.